Craig-Hallum analyst Matt Hewitt maintained a Buy rating on Clover Health Investments (CLOV – Research Report) today. The company’s shares closed yesterday at $3.72. Discover outperforming ...
Hosted on MSN1mon
Clover Health draws new Buy at Craig-Hallum despite sharp YTD gainsCraig-Hallum launched its coverage of Clover Health Investments (NASDAQ:CLOV) with a Buy recommendation and $6 per share target on Tuesday despite the managed care firm's over three-fold rise in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback